About autism 1

About autism 1

He is responsible for technology due diligence and investment in seed/early-stage venture companies in the life sciences, with a focus on the biotech and healthcare sectors. (listed on the Mothers market in June 2013 and on the First Section in December 2015), where he was involved in deal sourcing, management team formation, business planning and business development. He has been involved in technology due diligence and investment in seed/early-stage venture companies in the life sciences, with a focus on the biotech and healthcare sectors. (listed on the Mothers market in June 2013 and on the First Section in December 2015), where he was involved in deal sourcing, management team formation, business planning and business development. He has been involved in technology due diligence and investment in seed/early-stage venture companies in the life sciences, with a focus on the biotech and healthcare sectors. (listed on the Mothers market in June 2013 and on the First Section in December 2015), where he was involved in deal sourcing, management team formation, business planning and business development.
2021.03.18

He is responsible for technology due diligence and investment in seed/early-stage venture companies in the life sciences, with a focus on the biotech and healthcare sectors.

He is responsible for technology due diligence and investment in seed/early-stage venture companies in the life sciences, with a focus on the biotech and healthcare sectors. (listed on the Mothers market in June 2013 and on the First Section in December 2015), where he was involved in deal sourcing, management team formation, business planning and business development. He has been involved in technology due diligence and investment in seed/early-stage venture companies in the life sciences, with a focus on the biotech and healthcare sectors. (listed on the Mothers market in June 2013 and on the First Section in December 2015), where he was involved in deal sourcing, management team formation, business planning and business development. He has been involved in technology due diligence and investment in seed/early-stage venture companies in the life sciences, with a focus on the biotech and healthcare sectors. (listed on the Mothers market in June 2013 and on the First Section in December 2015), where he was involved in deal sourcing, management team formation, business planning and business development.